NEW YORK UNIVERSITY MEDICAL CENTER 
A private university in the public service 
School of Medicine 
550 FIRST AVENUE, NEW YORK, N.Y. 10016 
CABLE ADDRESS: NYUMEDIC 
Department of Pharmacology 
(212) 340 - 7122 
January 31, 1983 
Dr. William J. Gartland 
Director, Office Recombinant DNA 
N1H 
Bethesda, MD 20205 
Dear Dr. Gartland: 
The following are in response to your solicitation of comments on revised 
guidelines for research involving recombinant DNA. 
1. The new August 1982 Guidelines are well organized and convenient to 
use. A subject index, referring to specific organisms, vectors, etc. 
might facilitate the search for the pertinent information. Also a 
packet containing only information for the investigator would be 
useful . 
2. Our internal forms require a brief description of the DNA- relevant 
experiments and allow expeditious review by the IBC which does not 
require inordinate amount of time. 
3. To date we have not encountered problems with the guidelines 
regarding their laxity or stringency. 
4. In the past we met once a month, but in recent months have managed 
our review process by telephone. Periodic meetings are held to 
review developments and procedures. Our main concern is how to keep 
the investigators apprised of changes in guidelines. A specific 
packet for the P.I. could be distributed through the IBC. 
5. The IBC at New York University has no responsibility other than that 
relating to recombinant DNA. These limitations were in the initial 
charge to the IBC and as such are favored by the members of the IBC. 
A broader charge would require reconstitution of the IBC. 
[ 602 ] 
